Bruker Corp. Stock
Price
Target price
€35.48
€35.48
2.440%
0.85
2.440%
€45.57
06.02.26 / Tradegate
WKN: 813534 / Symbol: BRKR / Name: Bruker / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bruker Corp. Stock
There is an upward development for Bruker Corp. compared to yesterday, with an increase of €0.85 (2.440%).
With 17 Buy predictions and not the single Sell prediction the community is currently very high on Bruker Corp..
As a result the target price of 45 € shows a positive potential of 26.83% compared to the current price of 35.48 € for Bruker Corp..
For the coming years our community has positive and negative things to say abot the Bruker Corp. stock. Criterium "Revenue growth" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 2.440% | -5.032% | -21.278% | -34.199% | -13.018% | - | - |
| Healthequity Inc. | 0.000% | -7.639% | -18.405% | -37.850% | -14.744% | 20.909% | -5.674% |
| Omnicell Inc. | -16.410% | -20.098% | -18.500% | -23.113% | -15.979% | -37.905% | -68.952% |
| Myriad Genetics | -0.470% | -8.936% | -22.883% | -65.203% | -19.245% | -76.116% | -82.032% |
Comments
Bruker (NASDAQ:BRKR) had its "buy" rating reaffirmed by analysts at Guggenheim.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) had its "buy" rating reaffirmed by analysts at Guggenheim.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) had its price target raised by analysts at JPMorgan Chase & Co. from $50.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a